These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35875322)

  • 1. Prioritizing noncommunicable diseases in the Americas region in the era of COVID-19.
    Luciani S; Agurto I; Caixeta R; Hennis A
    Rev Panam Salud Publica; 2022; 46():e83. PubMed ID: 35875322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncommunicable diseases in the Americas: a review of the Pan American Health Organization's 25-year program of work.
    Luciani S; Nederveen L; Martinez R; Caixeta R; Chavez C; Sandoval RC; Severini L; Cerón D; Gomes AB; Malik S; Gomez F; Ordunez P; Maza M; Monteiro M; Hennis A
    Rev Panam Salud Publica; 2023; 47():e13. PubMed ID: 37114168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the NCD service capacity and disruptions due to COVID-19? Results from the WHO non-communicable disease country capacity survey in the Americas region.
    Luciani S; Caixeta R; Chavez C; Ondarsuhu D; Hennis A
    BMJ Open; 2023 Mar; 13(3):e070085. PubMed ID: 36863746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on service delivery for noncommunicable diseases in the Eastern Mediterranean Region.
    Hammerich A; Fouad H; Elrayah EE; Slama S; El-Awa F; El-Berri H; Abdel Latif N
    East Mediterr Health J; 2022 Jul; 28(7):469-477. PubMed ID: 35959662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A narrative review of gaps in the provision of integrated care for noncommunicable diseases in India.
    Pati MK; Swaroop N; Kar A; Aggarwal P; Jayanna K; Van Damme W
    Public Health Rev; 2020; 41():8. PubMed ID: 32435518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting roles of community health workers in the prevention and management of noncommunicable disease during the COVID-19 pandemic: a scoping review.
    Haregu T; Delobelle P; Shrestha A; Panniyammakal J; Thankappan KR; Parasuraman G; Schouw D; Ramalingam A; Issaka A; Cao Y; Levitt N; Oldenburg B
    Health Policy Plan; 2024 Aug; 39(7):771-781. PubMed ID: 38910332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. China's Efforts on Management, Surveillance, and Research of Noncommunicable Diseases: NCD Scorecard Project.
    Zhu XL; Luo JS; Zhang XC; Zhai Y; Wu J
    Ann Glob Health; 2017; 83(3-4):489-500. PubMed ID: 29221521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health system adaptions to improve care for people living with non-communicable diseases during COVID-19 in low-middle income countries: A scoping review.
    Baatiema L; Sanuade OA; Allen LN; Abimbola S; Hategeka C; Koram KA; Kruk ME
    J Glob Health; 2023 Mar; 13():06006. PubMed ID: 36862142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
    Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
    Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
    Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
    BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated approach for noncommunicable disease management in the Americas.
    Luciani S; Agurto I; Holder R; Caixeta R; Hennis AJ
    Rev Panam Salud Publica; 2022; 46():e154. PubMed ID: 36071922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of collaborative, multistakeholder partnerships in reshaping the health management of patients with noncommunicable diseases during and after the COVID-19 pandemic.
    Monaco A; Casteig Blanco A; Cobain M; Costa E; Guldemond N; Hancock C; Onder G; Pecorelli S; Silva M; Tournoy J; Trevisan C; Votta M; Yfantopoulos J; Yghemonos S; Clay V; Mondello Malvestiti F; De Schaetzen K; Sykara G; Donde S
    Aging Clin Exp Res; 2021 Oct; 33(10):2899-2907. PubMed ID: 34319512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Health Tools for Managing Noncommunicable Diseases During and After the COVID-19 Pandemic: Perspectives of Patients and Caregivers.
    Monaco A; Palmer K; Holm Ravn Faber N; Kohler I; Silva M; Vatland A; van Griensven J; Votta M; Walsh D; Clay V; Yazicioglu MC; Ducinskiene D; Donde S
    J Med Internet Res; 2021 Jan; 23(1):e25652. PubMed ID: 33464206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
    Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of noncommunicable diseases and implementation challenges of National NCD Programmes in India.
    Thakur JS; Paika R; Singh S
    Med J Armed Forces India; 2020 Jul; 76(3):261-267. PubMed ID: 32773927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world data for precision public health of noncommunicable diseases: a scoping review.
    Canfell OJ; Kodiyattu Z; Eakin E; Burton-Jones A; Wong I; Macaulay C; Sullivan C
    BMC Public Health; 2022 Nov; 22(1):2166. PubMed ID: 36434553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reported impact of non-communicable disease investment cases in 13 countries.
    Troisi G; Small R; Chestnov R; Andreasyan D; Khachatryan H; Phillips EA; Malcolm T; Kol H; Khodjaeva N; Gebremichael M; Worku Tessema A; Workneh AB; Davidson T; Harris M; Ibraeva N; Nurmatova A; Altymysheva A; Go JJ; Kontsevaya A; Hanbunjerd K; Bunluesin S; Nieveras O; Ekinci B; Keskinkiliç B; Erguder T; Akiya OC; Kasule H; Nakanjako A; Shukurov S; Kasymova N; Banda P; Kakoma E; Bakyaita NN; Kulikov A; Tarlton D; Putoud N; Chiossi S; Webb D; Banatvala N
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38599663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncommunicable Diseases Prevention Policies and Their Implementation in Africa: A Systematic Review.
    Kassa MD; Grace JM
    Public Health Rev; 2021; 42():1604310. PubMed ID: 35295954
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementation of Policies and Strategies for Control of Noncommunicable Diseases in Malawi: Challenges and Opportunities.
    Lupafya PC; Mwagomba BL; Hosig K; Maseko LM; Chimbali H
    Health Educ Behav; 2016 Apr; 43(1 Suppl):64S-9S. PubMed ID: 27037149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Non-Communicable Diseases in Kosovo: A Scoping Review.
    Hoxha I; Apuk V; Kryeziu B; Rashiti P; Aliu M; Aquines AG; Khan O; Nguyen HTH
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.